Global Vascular Grafts Market to reach USD 3,153.39 million by 2032 at a CAGR of 6.86% by 2032, Evaluates DelveInsight

According to DelveInsight's analysis, The increasing prevalence of cardiovascular disorders, along with risk factors like hypertension, diabetes, and obesity, is fueling the demand for surgical interventions, thereby supporting the growth of the vascular graft market. Moreover, greater awareness and the expansion of cardiovascular screening programs are enabling earlier diagnosis and timely treatment, further driving the need for vascular grafts.

DelveInsight's "Vascular Grafts Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Vascular Grafts companies actively working in the market.

To know more about why North America is leading the market growth in the Vascular Grafts market, get a snapshot of the report Vascular Grafts Market Trends
https://www.delveinsight.com/sample-request/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Vascular Grafts Overview
Vascular grafts are artificial or biological tubes used to replace, repair, or bypass damaged or diseased blood vessels. They help restore normal blood flow in patients with conditions such as atherosclerosis, aneurysms, or vascular injuries. These grafts can be made from synthetic materials (like Dacron or ePTFE), biological tissues (from human or animal sources), or hybrid materials combining both. Vascular grafts are commonly used in procedures like coronary artery bypass surgery, hemodialysis access, and peripheral artery reconstruction. Their main goal is to ensure durable and efficient blood circulation.

DelveInsight Analysis: The global vascular grafts market size was estimated at USD 1,863.09 million in 2024 and is expected to grow at a CAGR of 6.86% from 2025 to 2032, reaching USD 3,153.39 million by 2032.

Vascular Grafts Market Insights
Geographically, North America is anticipated to hold the largest share of the vascular grafts market in 2024 compared to other regions. This can be attributed to the high prevalence of vascular diseases, a robust healthcare infrastructure, and widespread use of advanced surgical techniques like endovascular repair. The region also benefits from the presence of major medical device companies, increased healthcare expenditure, and favorable reimbursement policies. Furthermore, growing awareness about early diagnosis and treatment of conditions such as abdominal aortic aneurysms, along with an expanding elderly population, reinforces North America's leading position in the vascular grafts market.

To read more about the latest highlights related to Vascular Grafts, get a snapshot of the key highlights entailed in the Vascular Grafts Market Insights
https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Vascular Grafts Market Report
• In November 2024, Healionics received FDA Breakthrough Device designation for its StargraftTM arteriovenous graft, intended to improve outcomes in dialysis access by reducing infection and thrombosis risks
• In January 2024, W. L. Gore & Associates announced FDA approval for the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE), the first off-the-shelf endovascular graft for the treatment of complex aneurysmal disease involving the visceral aorta.
• Thus, owing to such developments in the market, rapid growth will be observed in the Vascular Grafts market during the forecast period

Key Players in the Vascular Grafts Market
Some of the key market players operating in the Vascular Grafts market include- BD, Getinge AB, Medtronic plc., B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, W. L. Gore & Associates, Inc., JOTEC GmbH, LeMaitre Vascular, Inc., Perouse Medical, CryoLife, Inc, BIOVIC Sdn Bhd, Abbott, Bentley, BioIntegral Surgical, Cook, Merit Medical Systems, SCITECH., Vascular Graft Solutions, Healionics, and others.

Which MedTech key players in the Vascular Grafts market are set to emerge as the trendsetter explore @ Key Vascular Grafts Companies
https://www.delveinsight.com/sample-request/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Vascular Grafts Market Landscape
Moreover, companies are actively driving market growth by introducing innovative abdominal grafts. For instance, Medtronic offers the EndurantTM II Stent Graft System, designed for AAA treatment with enhanced conformability and user-friendliness, while Gore Medical provides the GORE® EXCLUDER® AAA Endoprosthesis, recognized for its reliability and long-term performance. Increased product development efforts among key players are further accelerating the vascular grafts market. For example, in August 2024, Terumo India, the Indian subsidiary of Terumo Corporation, launched the TREO® Stent-Graft System, an advanced solution for Endovascular Aneurysm Repair (EVAR). Specifically designed for treating infrarenal abdominal aortic aneurysms in adults with suitable anatomies, it is the only EVAR graft featuring both suprarenal and infrarenal active fixation.
Collectively, these initiatives are expected to strengthen this market segment, thereby driving the overall growth of the global vascular grafts market.

Scope of the Vascular Grafts Market Report
• Coverage: Global
• Study Period: 2022-2032
• Vascular Grafts Market Segmentation By Product Type: Endovascular Grafts [Abdominal Grafts and Thoracic Grafts], Access Grafts, Peripheral Grafts, and Others
• Vascular Grafts Market Segmentation By Material: Synthetic [Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, and Others
• Vascular Grafts Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers, and Others
• Vascular Grafts Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Vascular Grafts Companies: BD, Getinge AB, Medtronic plc., B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, W. L. Gore & Associates, Inc., JOTEC GmbH, LeMaitre Vascular, Inc., Perouse Medical, CryoLife, Inc, BIOVIC Sdn Bhd, Abbott, Bentley, BioIntegral Surgical, Cook, Merit Medical Systems, SCITECH., Vascular Graft Solutions, Healionics, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Vascular Grafts market will grow by 2032? Click to get a snapshot of the Vascular Grafts Market Analysis
https://www.delveinsight.com/sample-request/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.